Effect of a cheese rich in angiotensin-converting enzyme-inhibiting peptides (Gamalost^®) and a Gouda-type cheese on blood pressure: results of a randomised trial

References

• Alwan A. Global status report on noncommunicable diseases 2010. 2011; World Health Organization. Available from: http://www.who.int/nmh/publications/ncd_report_full_en.pdf [cited 4 April 2015].
   Google Scholar
• World Health Organization. The top 10 causes of death. 2014. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/ [cited 22 August 2014].
   Google Scholar
• MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, etal. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990; 335(8692): 765–74. [PubMed Abstract].
   Google Scholar
• Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, etal. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2224–60. doi: http://dx.doi.org/10.1016/S0140-6736(12)61766-8 [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006; 47(2): 296–308. [PubMed Abstract].
   Google Scholar
• Sacks FM, Svetkey S, Vollmer WM, Appel LJ, Bray GA, Harsha D, etal. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001; 344(1):3–10. doi: http://dx.doi.org/10.1056/NEJM200101043440101 [PubMed Abstract].
   Google Scholar
• He J, Wofford MR, Reynolds K, Chen J, Chen CS, Myers L, etal. Effect of dietary protein supplementation on blood pressure: a randomised, controlled trial. Circulation. 2011; 124(5): 589–95. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Wang L, Manson JE, Buring JE, Lee IM, Sesso HD. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension. 2008; 51(4):1073–9. doi: http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.107821 [PubMed Abstract].
   Google Scholar
• Houston M. The importance of potassium in managing hypertension. Curr Hypertens Rep. 2011; 13: 309–17. [PubMed Abstract].
   Google Scholar
• Korhonen H, Pihlanto A. Bioactive peptides: production and functionality. Int Dairy J. 2006; 16: 945–60.
   Web of Science ®Google Scholar
• Silva SV, Malcata FX. Caseins as source of bioactive peptides. Int Dairy J. 2005; 15: 1–15.
   Web of Science ®Google Scholar
• Pritchard SR, Phillips M, Kailasapathy K. Identification of bioactive peptides in commercial Cheddar cheese. Food Res Int. 2010; 43: 1545–8.
   Web of Science ®Google Scholar
• Gomez-Ruiz JA, Ramos M, Recio I. Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. Int Dairy J. 2002; 12: 697–706.
   Web of Science ®Google Scholar
• Lignitto L, Cavatorta V, Balzan S, Gabai G, Galaverna G, Novelli E, etal. Angiotensin-converting, enzyme inhibitory activity of water-soluble extracts of Asiago d'allevo cheese. Int Dairy J. 2010; 20(1): 11–17.
   Web of Science ®Google Scholar
• Qureshi TM, Vegarud GE, Abrahamsen RK, Skeie S. Characterization of the Norwegian autochthonous cheese Gamalost and its angiotensin I-converting enzyme (ACE) inhibitory activity during ripening. Dairy Sci Technol. 2012; 92(6):613–25. doi: http://dx.doi.org/10.1007/s13594-012-0078-1.
   Google Scholar
• [PubMed CentralFull Text] Pripp A. Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomised controlled trials. Food Nutr Res 2008; 52. doi: 10.3402/fnr.v52i0.1641.
   Google Scholar
• Pripp AH, Sorensen R, Stepamak L, Sorhaug T. Relationship between proteolysis and angiotensin-I-converting enzyme inhibition in different cheeses. LWT Food Sci Technol. 2006; 39(6):677–83. doi: http://dx.doi.org/10.1016/j.lwt.2005.03.018.
   Google Scholar
• Qureshi TM, Vegarud GE, Abrahamsen RK, Skeie S. Angiotensin 1-converting enzyme (ACE) inhibitory activity of the Norwegian autochthonous cheese Gamalost and Norvegia after in vitro human gastrointestinal digestion. J Dairy Sci. 2013; 96(2):838–53. doi: http://dx.doi.org/10.3168/jds.2012-5993 [PubMed Abstract].
   Google Scholar
• Sieber R, Butikofer U, Egger C, Portmann R, Walther B, Wechsler D. ACE-inhibitory activity and ACE-inhibiting peptides in different cheese varieties. Dairy Sci Technol. 2010; 90(1):47–73. doi: http://dx.doi.org/10.1051/dst/2009049.
   Google Scholar
• Nilsen R, Pripp AH, Høstmark AT, Haug A, Skeie S. Short communication: is consumption of a cheese rich in angiotensin-converting enzyme-inhibiting peptides, such as the Norwegian cheese Gamalost, associated with reduced blood pressure?. J Dairy Sci. 2014; 97(5):2662–8. doi: http://dx.doi.org/10.3168/jds.2013-7479 [PubMed Abstract].
   Google Scholar
• Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, etal. Recommendations for blood pressure measurement in humans and experimental animals. Hypertension. 2005; 45(1):142–61. doi: http://dx.doi.org/10.1161/01.HYP.0000150859.47929.8e [PubMed Abstract].
   Google Scholar
• Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, etal. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press. 2014; 23(1): 3–16. [PubMed Abstract].
   Google Scholar
• WHO. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8–11 December 2008. 2011; Geneva, Switzerland: WHO.
   Google Scholar
• Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005; 34: 215–20. [PubMed Abstract].
   Google Scholar
• Modesti PA. Season, temperature and blood pressure: a complex interaction. Eur J Intern Med. 2013; 24(7): 604–7. [PubMed Abstract].
   Google Scholar
• Toledo E, Hu FB, Estruch R, Buil-Cosiales P, Corella D, Salas-Salvado J, etal. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomised controlled trial. BMC Med. 2013; 11: 207. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995; 155(7): 701–9. [PubMed Abstract].
   Google Scholar
• Engberink MF, Schouten EG, Kok FJ, van Mierlo LAJ, Brouwer IA, Geleijnse JM. Lactotripeptides show no effect on human blood pressure. Hypertension. 2008; 51(2):399–405. doi: http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.098988 [PubMed Abstract].
   Google Scholar
• Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr. 2005; 24(4): 257–65. [PubMed Abstract].
   Google Scholar
• Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, etal. Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers. J Hum Hypertens. 2013; 27(2): 126–30. [PubMed Abstract].
   Google Scholar
• Rodriguez-Leyva D, Weighell W, Edel AL, LaVallee R, Dibrov E, Pinneker R, etal. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013; 62(6): 1081–9. [PubMed Abstract].
   Google Scholar
• Conway V, Couture P, Gauthier S, Pouliot Y, Lamarche B. Effect of buttermilk consumption on blood pressure in moderately hypercholesterolemic men and women. Nutrition. 2014; 30(1): 116–19. [PubMed Abstract].
   Google Scholar
• Katz DL, Davidhi A, Ma Y, Kavak Y, Bifulco L, Njike VY. Effects of walnuts on endothelial function in overweight adults with visceral obesity: a randomised, controlled, crossover trial. J Am Coll Nutr. 2012; 31(6): 415–23. [PubMed Abstract].
   Google Scholar
• Sumner DJ, Meredith PA, Howie CA, Elliott HL. Initial blood pressure as predictor of the response to antihypertensive therapy. Br J Clin Pharmacol. 1988; 26(6): 715–20. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Fekete AA, Givens DI, Lovegrove JA. Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials. Nutrients. 2015; 7: 659–81. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Franklin SS, Thijs L, Hansen TW, O'Brien E, Staessen JA. White-coat hypertension new insights from recent studies. Hypertension. 2013; 62(6): 982–7. [PubMed Abstract].
   Google Scholar
• Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood pressure monitoring. Task force V: white-coat hypertension. Blood Press Monit. 1999; 4(6): 333–41. [PubMed Abstract].
   Google Scholar
• O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, etal. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013; 31(9): 1731–68. [PubMed Abstract].
   Google Scholar